Pancreatic Cancer Research

ResearcherGifu University HospitalActive in the last 2 years

Mitsuru Okuno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8989-6437; OpenAlex author ID A5026303112, A5126317406. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperative Endoscopic Biliary Obstruction in Pan… Co-author DOI 10.1007/s10620-026-10136-z↗
  2. A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure. Co-author DOI 10.1007/s12032-024-02438-x↗
  3. Covered self-expandable metallic stent versus plastic stent for preoperative endoscopic biliary drainage in patients with pancreatic cancer: a multi-center ret… Co-author DOI 10.1080/00365521.2021.2015802↗
  4. Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure. Co-author DOI 10.3390/jcm8060761↗
  5. A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer. Co-author DOI 10.18632/oncotarget.22795↗
  6. The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.7424↗
  7. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer. Co-author DOI 10.3390/ijms17010137↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahito Shimizu · 6 shared papers, 2016–2026 · strength 0.68
  2. Takuji Iwashita · 5 shared papers, 2016–2026 · strength 0.60
  3. Shinya Uemura · 4 shared papers, 2017–2026 · strength 0.55
  4. Akinori Maruta · 3 shared papers, 2017–2026 · strength 0.45
  5. Hironao Ichikawa · 2 shared papers, 2022–2026 · strength 0.39
  6. Naoki Mita · 2 shared papers, 2019–2026 · strength 0.35
  7. Ryuichi Tezuka · 2 shared papers, 2022–2024 · strength 0.34
  8. Kensaku Yoshida · 3 shared papers, 2017–2022 · strength 0.29
  9. Ichiro Yasuda · 3 shared papers, 2016–2022 · strength 0.26
  10. Eiichi Tomita · 1 shared paper, 2024 · strength 0.21
  11. Seiji Adachi · 2 shared papers, 2016 · strength 0.13
  12. Osamu Kozawa · 2 shared papers, 2016 · strength 0.13
  13. Junji Kawaguchi · 2 shared papers, 2016–2017 · strength 0.12
  14. Masanori Nakashima · 1 shared paper, 2016 · strength 0.05
  15. Hisataka Moriwaki · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.